News

Flickr/United State Mission Geneva
GHTC issues statement on equitable access to medicines at WHO Executive Board meeting

GHTC issued a statement at the 144th session of the World Health Organization (WHO) Executive Board supporting the ongoing efforts of WHO to increase equitable access to medicines, vaccines, and other health products. The statement, which was issued in partnership with the Global Health Council, the American Academy of Pediatrics, and NCD Child, encourages WHO to support a comprehensive approach to improving access that considers affordability, acceptability, availability, and quality.

PDF

CDC/James Gathany
GHTC responds to RFI on CARB National Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI)on the next National Action Plan for Combatting Antibiotic Resistant Bacteria (CARB) 2020-2025. GHTC’s submission encouraged the prioritization of R&D to combat antimicrobial resistance globally.

PDF

PATH/Patrick McKern
GHTC applauds passage of Global Health Innovation Act

GHTC applauds yesterday's Senate passage of the Global Health Innovation Act, a bipartisan bill to support efforts by the US Agency for International Development to develop affordable, appropriate technologies to advance the health of people in the world’s poorest places. The bill, which has already passed the House of Representatives, now heads to the President’s desk where he is expected to sign it into law.

Learn More

PATH/Patrick McKern
GHTC sends letter of support for National Biodefense Strategy

GHTC sent a letter to Secretary of Health and Human Services Alex Azar in support of the National Biodefense Strategy released by the Administration in September. The letter commends the goals in the strategy aimed at accelerating basic and applied R&D of new antimicrobials, novel therapeutics, vaccines, and diagnostic tests; promoting increased global capacities for R&D, and integrating R&D into federal planning before and during a potential bio-incident.

PDF

Senator Blunt, Rep. DeLauro, and developers of child-friendly TB medicines honored with GHTC Innovating for Impact Awards

GHTC yesterday honored Senator Roy Blunt (R-MO) and Congresswoman Rosa DeLauro (D-CT) at its second annual Innovating for Impact Awards, which celebrates US policymakers and partnerships driving progress in global health innovation. GHTC also recognized the partnership that developed and introduced improved child-friendly tuberculosis (TB) medicines, making these transformative treatments available to children in need worldwide.

Learn More

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide